Clinical trial
A Prospective Study of Circulating Tumor DNA Detection by Targeted Sequencing in Surgical Non-Small Cell Lung Cancer Patients
NCT02645318 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Study of Circulating Tumor DNA Detection by Targeted Sequencing in Surgical Non-Small Cell Lung Cancer Patients
- Lead sponsor
- Peking University People's Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 31, 2015
- Completion date
- July 31, 2015
- Enrollment
- 95 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.